Evidence map›Paper›PMID 24901642›Full record

ReviewPLoS neglected tropical diseases2014

African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights.

Luc E Coffeng, Wilma A Stolk, Honorat G M Zouré, J Lennert Veerman, Koffi B Agblewonu, Michele E Murdoch, Mounkaila Noma, Grace Fobi, Jan Hendrik Richardus, Donald A P Bundy and 3 more

Abstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Procedure for Handling and Storage ofTropical medicine and infectious disease · 2023
    Article
  6. Article
  7. Article
  8. NTD Diagnostics for Disease Elimination: A Review.Diagnostics (Basel, Switzerland) · 2020
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Onchodermatitis: Where Are We Now?Tropical medicine and infectious disease · 2018
    Review
  16. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luc E CoffengDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Wilma A StolkDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Honorat G M ZouréAfrican Programme for Onchocerciasis Control, Ouagadougou, Burkina Faso.
J Lennert VeermanDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; School of Population Health, The University of Queensland, Herston, Australia.
Koffi B AgblewonuAfrican Programme for Onchocerciasis Control, Ouagadougou, Burkina Faso.
Michele E MurdochDepartment of Dermatology, Watford General Hospital, Watford, United Kingdom.
Mounkaila NomaAfrican Programme for Onchocerciasis Control, Ouagadougou, Burkina Faso.
Grace FobiAfrican Programme for Onchocerciasis Control, Ouagadougou, Burkina Faso.
Jan Hendrik RichardusDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Donald A P BundyHuman Development Network, The World Bank, Washington, D.C., United States of America.
Dik HabbemaDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Sake J de VlasDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Uche V AmazigoIndependent Consultant, Enugu, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disability EvaluationAfrica South of the SaharaCommunicable Disease ControlHumansOnchocerciasisPruritusVision Disorders

Identifiers

PMID24901642
PMCPMC4046979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.